Compile Data Set for Download or QSAR
Report error Found 57 Enz. Inhib. hit(s) with all data for entry = 50014159
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138858([(S)-1-(4-Phenyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 0.210nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138853([(S)-1-(4-Bromo-1H-pyrazol-3-ylaminooxalyl)-pentyl...)
Affinity DataIC50: 0.240nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138876([(S)-1-(4-Fluoro-1H-indazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 0.260nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138866([(S)-1-(1-Methyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 0.410nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138869([(S)-1-(4-Methyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 0.470nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138879([(S)-1-(5-Phenyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 0.650nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138871([(S)-1-(5-Methyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 0.710nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138868([(S)-1-(1H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbam...)
Affinity DataIC50: 0.770nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138870([(S)-1-(4-Cyano-1H-pyrazol-3-ylaminooxalyl)-pentyl...)
Affinity DataIC50: 0.910nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138846(3-[(S)-3-(1-Isopropyl-2-methyl-propoxycarbonylamin...)
Affinity DataIC50: 1.70nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138858([(S)-1-(4-Phenyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138842([(S)-1-(4-Bromo-1H-pyrazol-3-ylaminooxalyl)-pentyl...)
Affinity DataIC50: 2.54nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138864([(S)-1-(Isoquinolin-3-ylaminooxalyl)-pentyl]-carba...)
Affinity DataIC50: 4.80nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138852([(S)-1-(Isoxazol-3-ylaminooxalyl)-pentyl]-carbamic...)
Affinity DataIC50: 5.10nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138869([(S)-1-(4-Methyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 5.5nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138878([(S)-1-(Thiophen-2-ylmethyl)-aminooxalyl]-pentyl)-...)
Affinity DataIC50: 9.20nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138866([(S)-1-(1-Methyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 11nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138879([(S)-1-(5-Phenyl-1H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 12nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138868([(S)-1-(1H-Pyrazol-3-ylaminooxalyl)-pentyl]-carbam...)
Affinity DataIC50: 13nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138843({(S)-1-Cyclohexylmethyl-2-oxo-2-[(thiophen-2-ylmet...)
Affinity DataIC50: 14nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138865([(S)-1-(2-Cyclobutyl-2H-pyrazol-3-ylaminooxalyl)-p...)
Affinity DataIC50: 15nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138854([(S)-1-(2-Phenyl-2H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 15nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138849([(S)-1-(2-Isopropyl-2H-pyrazol-3-ylaminooxalyl)-pe...)
Affinity DataIC50: 17nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138847([(S)-1-(2-Cyclopentyl-2H-pyrazol-3-ylaminooxalyl)-...)
Affinity DataIC50: 20nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138877([(S)-1-(2-Cyclohexyl-2H-pyrazol-3-ylaminooxalyl)-p...)
Affinity DataIC50: 22nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138859([(S)-3-Methyl-1-(thiophen-2-ylmethyl)-aminooxalyl]...)
Affinity DataIC50: 24nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138867([(S)-1-(2-Pyridin-4-yl-2H-pyrazol-3-ylaminooxalyl)...)
Affinity DataIC50: 25nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138855([(S)-1-(2-Ethyl-2H-pyrazol-3-ylaminooxalyl)-pentyl...)
Affinity DataIC50: 26nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138848([(S)-1-(2-Cyclopropylmethyl-2H-pyrazol-3-ylaminoox...)
Affinity DataIC50: 27nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138875({(S)-1-Benzyl-2-oxo-2-[(thiophen-2-ylmethyl)-carba...)
Affinity DataIC50: 27nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138841([(S)-1-(Pyridin-2-ylaminooxalyl)-pentyl]-carbamic ...)
Affinity DataIC50: 32nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138851([(S)-1-(2-Methyl-2H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 32nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138872([(S)-1-(2-Isobutyl-2H-pyrazol-3-ylaminooxalyl)-pen...)
Affinity DataIC50: 39nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138874([(S)-1-(Thiazol-2-ylaminooxalyl)-pentyl]-carbamic ...)
Affinity DataIC50: 40nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138860([(S)-2-Methyl-1-(thiophen-2-ylmethyl)-aminooxalyl]...)
Affinity DataIC50: 47nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50137790([(S)-1-(4-Bromo-1H-pyrazol-3-ylaminooxalyl)-pentyl...)
Affinity DataIC50: 51nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138845([(S)-1-(Pyrazin-2-ylaminooxalyl)-pentyl]-carbamic ...)
Affinity DataIC50: 52nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138844({(S)-1-[2-(3,3-Dimethyl-butyl)-2H-pyrazol-3-ylamin...)
Affinity DataIC50: 62nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138850([(S)-1-(2-Pyridin-2-yl-2H-pyrazol-3-ylaminooxalyl)...)
Affinity DataIC50: 62nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138861([(S)-1-([1,3,4]Thiadiazol-2-ylaminooxalyl)-pentyl]...)
Affinity DataIC50: 83nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138857([(S)-2-Methyl-1-(thiophen-2-ylmethyl)-aminooxalyl]...)
Affinity DataIC50: 87nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138863([(S)-1-(Pyridin-3-ylaminooxalyl)-pentyl]-carbamic ...)
Affinity DataIC50: 95nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138862([(S)-1-(Quinolin-2-ylaminooxalyl)-pentyl]-carbamic...)
Affinity DataIC50: 250nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138873({(S)-1-Methyl-2-oxo-2-[(thiophen-2-ylmethyl)-carba...)
Affinity DataIC50: 360nMAssay Description:Concentration required to inhibit 50% of cysteine protease cathepsin K of humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138867([(S)-1-(2-Pyridin-4-yl-2H-pyrazol-3-ylaminooxalyl)...)
Affinity DataIC50: 470nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138854([(S)-1-(2-Phenyl-2H-pyrazol-3-ylaminooxalyl)-penty...)
Affinity DataIC50: 790nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138849([(S)-1-(2-Isopropyl-2H-pyrazol-3-ylaminooxalyl)-pe...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138847([(S)-1-(2-Cyclopentyl-2H-pyrazol-3-ylaminooxalyl)-...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138865([(S)-1-(2-Cyclobutyl-2H-pyrazol-3-ylaminooxalyl)-p...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Rat)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50138850([(S)-1-(2-Pyridin-2-yl-2H-pyrazol-3-ylaminooxalyl)...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of cysteine protease cathepsin K of ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: